Recombinant multi-species peptide YY/PYY protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine peptide YY/PYY protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the neuropeptide Y (NPY) family of peptides. The encoded preproprotein is proteolytically processed to generate two alternative peptide products that differ in length by three amino acids. These peptides, secreted by endocrine cells in the gut, exhibit different binding affinities for each of the neuropeptide Y receptors. Binding of the encoded peptides to these receptors mediates regulation of pancreatic secretion, gut mobility and energy homeostasis. Rare variations in this gene could increase susceptibility to obesity and elevated serum levels of the encoded peptides may be associated with anorexia nervosa. [provided by RefSeq, Feb 2016]
The Alternative Names of target: peptide YY, PYY,Peptide YY,PYY,PYY-I, Peptide tyrosine tyrosine,PYY1,PYY-I

Target products collectionGo to peptide YY/PYY products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T24127-Ab-1/ GM-Tg-hg-T24127-Ab-2 Human peptide YY/PYY protein Human
GM-Tg-rg-T24127-Ab-1/ GM-Tg-rg-T24127-Ab-2 Rat peptide YY/PYY protein Rat
GM-Tg-mg-T24127-Ab-1/ GM-Tg-mg-T24127-Ab-2 Mouse peptide YY/PYY protein Mouse
GM-Tg-cynog-T24127-Ab-1/ GM-Tg-cynog-T24127-Ab-2 Cynomolgus/Rhesus macaque peptide YY/PYY monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-T24127-Ab-1/ GM-Tg-felg-T24127-Ab-2 Feline peptide YY/PYY protein Feline
GM-Tg-cang-T24127-Ab-1/ GM-Tg-cang-T24127-Ab-2 Canine peptide YY/PYY protein Canine
GM-Tg-bovg-T24127-Ab-1/ GM-Tg-bovg-T24127-Ab-2 Bovine peptide YY/PYY protein Bovine
GM-Tg-equg-T24127-Ab-1/ GM-Tg-equg-T24127-Ab-2 Equine peptide YY/PYY protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T24127-Ab-1/ GM-Tg-hg-T24127-Ab-2; GM-Tg-rg-T24127-Ab-1/ GM-Tg-rg-T24127-Ab-2;
GM-Tg-mg-T24127-Ab-1/ GM-Tg-mg-T24127-Ab-2; GM-Tg-cynog-T24127-Ab-1/ GM-Tg-cynog-T24127-Ab-2;
GM-Tg-felg-T24127-Ab-1/ GM-Tg-felg-T24127-Ab-2; GM-Tg-cang-T24127-Ab-1/ GM-Tg-cang-T24127-Ab-2;
GM-Tg-bovg-T24127-Ab-1/ GM-Tg-bovg-T24127-Ab-2; GM-Tg-equg-T24127-Ab-1/ GM-Tg-equg-T24127-Ab-2
Products Name peptide YY/PYY protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name peptide YY/PYY
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine peptide YY/PYY protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.